What is Gyre Therapeutics, Inc.'s total assets?

Gyre Therapeutics, Inc. (GYRE) reported total assets of $162.02M in Q1 2026.

How has Gyre Therapeutics, Inc.'s total assets changed year-over-year?

Gyre Therapeutics, Inc.'s total assets increased by 24.8% year-over-year, from $129.79M to $162.02M.

What is the long-term trend for Gyre Therapeutics, Inc.'s total assets?

Over 5 years (2020 to 2025), Gyre Therapeutics, Inc.'s total assets has grown at a 11.9% compound annual growth rate (CAGR), from $94.85M to $166.13M.

What does total assets mean?

The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.

Gyre Therapeutics, Inc. GYRE Total Assets

Total Assets at other companies

Eli LillyLLY

$116.58B+30.4%

Madrigal Pharmaceuticals, Inc.MDGL

$1.23B+23.1%

Viking TherapeuticsVKTX

$608.24M-29.8%

Theravance BiopharmaTBPH

$472.31M+37.5%

Rigel PharmaceuticalsRIGL

$504.61M+187%

Zevra Therapeutics, Inc.ZVRA

$278.58M+61.3%

Segments

By segment

See full

Gyre Pharmaceuticals$137.35M+12.3%

Gyre$24.31M+244%

All Other Segments$357K-2.2%

Other financials

Income statement

See full

Revenue$22.5M+2.1%

Gross profit$21.3M+0.6%

Operating income-$9.4M-512%

Net income-$8.7M-422%

EPS (diluted)-$0.10—

Balance sheet

See full

Cash & equivalents$37.5M+149%

Total debt$823.0K-48.1%

Total equity$101.3M+48.7%

Cash flow

See full

Operating cash flow$3.2M+2,565%

CapEx$178.0K+45.9%

Free cash flow$3.0M+1,296%

Valuation

See full

Market cap$694.58M-4.7%

Enterprise value$657.9M-8.0%

P/S5.9×-1.3×

Profitability

See full

Gross margin95.1%-1.1pp

Operating margin-0.1%-10.4pp

Net margin6.3%+3.3pp

FCF margin2.6%—

Returns & leverage

See full

Return on equity8.2%+4.2pp

Debt / equity0×0.0×

Current ratio4.6×+1.0×

Where this comes from

Reported directly by Gyre Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s total assets?: Gyre Therapeutics, Inc. (GYRE) reported total assets of $162.02M in Q1 2026.
How has Gyre Therapeutics, Inc.'s total assets changed year-over-year?: Gyre Therapeutics, Inc.'s total assets increased by 24.8% year-over-year, from $129.79M to $162.02M.
What is the long-term trend for Gyre Therapeutics, Inc.'s total assets?: Over 5 years (2020 to 2025), Gyre Therapeutics, Inc.'s total assets has grown at a 11.9% compound annual growth rate (CAGR), from $94.85M to $166.13M.
What does total assets mean?: The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.